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Key Points
Question
Does the application of polyethylene glycol in addition to facial nerve neurorrhaphy improve functional and
anatomical outcomes after facial nerve injury?
Findings
In this animal experiment, the right facial nerve of 36 rats was cut and immediately repaired using
neurorrhaphy with or without the addition of polyethylene glycol. Compared with suture alone, the addition
of polyethylene glycol showed no significant benefit in functional outcomes, motoneuron survival, or
specificity of regrowth to target at any time points.
Meaning
The addition of polyethylene glycol to suturing may not be warranted in the surgical repair of facial nerve
injury.
Abstract
Importance
Functional and anatomical outcomes after surgical repair of facial nerve injury may be improved with the
addition of polyethylene glycol (PEG) to direct suture neurorrhaphy. The application of PEG has shown
promise in treating spinal nerve injuries, but its efficacy has not been evaluated in treatment of cranial nerve
injuries.
Objective
To determine whether PEG in addition to neurorrhaphy can improve functional outcomes and synkinesis
after facial nerve injury.
Design, Setting, and Subjects
In this animal experiment, 36 rats underwent right facial nerve transection and neurorrhaphy with addition
of PEG. Weekly behavioral scoring was done for 10 rats for 6 weeks and 14 rats for 16 weeks after the
operations. In the 16-week study, the buccal branches were labeled and tissue analysis was performed. In
the 6-week study, the mandibular and buccal branches were labeled and tissue analysis was performed.
Histologic analysis was performed for 10 rats in a 1-week study to assess the association of PEG with
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axonal continuity and Wallerian degeneration. Six rats served as the uninjured control group. Data were
collected from February 8, 2016, through July 10, 2017.
Intervention
Polyethylene glycol applied to the facial nerve after neurorrhaphy.
Main Outcomes and Measures
Functional recovery was assessed weekly for the 16- and 6-week studies, as well as motoneuron survival,
amount of regrowth, specificity of regrowth, and aberrant branching. Short-term effects of PEG were
assessed in the 1-week study.
Results
Among the 40 male rats included in the study, PEG addition to neurorrhaphy showed no functional benefit
in eye blink reflex (mean [SEM], 3.57 [0.88] weeks; 95% CI, −2.8 to 1.9 weeks; P = .70) or whisking
function (mean [SEM], 4.00 [0.72] weeks; 95% CI, −3.6 to 2.4 weeks; P = .69) compared with suturing
alone at 16 weeks. Motoneuron survival was not changed by PEG in the 16-week (mean, 132.1
motoneurons per tissue section; 95% CI, −21.0 to 8.4; P = .13) or 6-week (mean, 131.1 motoneurons per
tissue section; 95% CI, −11.0 to 10.0; P = .06) studies. Compared with controls, neither surgical group
showed differences in buccal branch regrowth at 16 (36.9 motoneurons per tissue section; 95% CI, −14.5 to
22.0; P = .28) or 6 (36.7 motoneurons per tissue section; 95% CI, −7.8 to 18.5; P = .48) weeks or in the
mandibular branch at 6 weeks (25.2 motoneurons per tissue section; 95% CI, −14.5 to 15.5; P = .99).
Addition of PEG had no advantage in regrowth specificity compared with suturing alone at 16 weeks
(15.3% buccal branch motoneurons with misguided projections; 95% CI, −7.2% to 11.0%; P = .84). After 6
weeks, the number of motoneurons with misguided projections to the mandibular branch showed no
advantage of PEG treatment compared with suturing alone (12.1% buccal branch motoneurons with
misguided projections; 95% CI, −8.2% to 9.2%; P = .98). In the 1-week study, improved axonal continuity
and muscular innervation were not observed in PEG-treated rats.
Conclusions and Relevance
Although PEG has shown efficacy in treating other nervous system injuries, PEG in addition to neurorraphy
was not beneficial in a rat model of facial nerve injury. The addition of PEG to suturing may not be
warranted in the surgical repair of facial nerve injury.
Level of Evidence
NA.
Introduction
Various treatments for facial nerve injury exist; however, none provide full functional recovery. Limitations
to functional recovery include the time required for degeneration and regrowth, number of outgrowths
crossing the injury site, and nonspecific regeneration resulting in a disrupted myotopic organization in the
central nervous system. Each contributes to impaired recovery and facial synkinesis after surgical repair of
facial nerve injury.  The use of polyethylene glycol (PEG) in addition to neurorrhaphy has shown promise
in mitigating these limitations.  However, the efficacy of PEG has only been evaluated in a mixed
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FNA and Neurorrhaphy
Addition of PEG to Neurorrhaphy
sensory and motor nerve but not in the treatment of a purely motor nerve, such as the rat facial nerve.
The PEG treatment protocol used by the laboratory of Bittner et al  includes application of a calcium-free
solution followed by the antioxidant methylene blue. After microsuture neurorrhaphy, the PEG solution is
applied to the suture site, resulting in nonspecific fusing of the apposed neuronal membranes.  Last, the site
is bathed in a calcium-containing solution to initiate sealing of any neuronal membranes not sealed by PEG.
Sequential application of these solutions acts to expel vesicles and prevent their accumulation on the
axotomized ends of the nerve, inhibits calcium influx that would initiate axonal injury signaling, and likely
removes the hydration barrier surrounding the axolemma, lowering the activation energy of membrane
fusion.  These actions have been shown to alter wallerian degeneration distal to the repair site, prevent
oxidative stress, and improve recovery times.  Polyethylene glycol has also been implicated in altering
specificity of regrowth. Robinson and Madison  observed PEG-impaired regrowth specificity after sciatic
nerve injury, but other groups  have challenged these findings.
Whether such PEG-mediated benefits will be reproducible and of therapeutic significance in treating facial
nerve injury remains unknown. We hypothesize that adding PEG to neurorrhaphy will improve functional
recovery, amount of axonal regrowth, and specificity of regrowth. To test this hypothesis, behavioral
scoring and anatomical analysis were performed at 3 times in a rat model.
Methods
Overview of Methods
We used a total of 40 male Wistar rats (200-400 g; Envigo), including 14 in the 16-week study, 10 in the 6-
week study, 10 in the 1-week study, and 6 in an uninjured control group. Animals at each point were divided
into those undergoing facial nerve axotomy (FNA) and suture neurorrhaphy with or without application of
PEG. The Institutional Animal Care and Use Committee of Indiana University School of Medicine
approved all experimental protocols.
Data were collected from February 8, 2016, through July 10, 2017. For all surgical procedures, animals
were anesthetized using 2.5% to 3.0% isoflurane in 99% oxygen at a rate of 1 L/min. All surgical sites were
closed using two to three 9-mm wound clips, which were removed at 1 postoperative week. Immediately
after surgery, 1 mL of buprenorphine hydrochloride was administered for pain management.
Surgical Groups
A 1.5-cm posterior-auricular incision was made on the right side of the head to
expose the main trunk of the facial nerve as it exits the stylomastoid foramen. Once 5 to 6 mm of the main
trunk was fully exposed, the nerve was fully transected 2 to 3 mm distal from its exit of the stylomastoid
foramen (Figure 1A).  Only the injured (right) facial motor nucleus (FMN) was quantified (Figure 1B).
Neurorrhaphy was performed using two 10-0 nylon sutures (AROSurgical) with care to only pass the needle
through the epineurium and prevent fraying and swelling of the nerve ending and subsequent protrusions
from the suture site.
For all repairs including PEG, before transection, the area was rinsed
with a calcium-free solution (Plasma-Lyte; Baxter International, Inc). After transection, the area was rinsed
a second time with the calcium-free solution, and 2 drops of methylene blue were applied to both ends of the
transected nerve. The area was rinsed a third time with the calcium-free solution to improve visibility.
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Neurorrhaphy was then performed as described in the previous section. We applied a 500mM PEG solution
(3.35 kDa; Sigma Aldrich) in sterile water to the suture site for 60 to 90 seconds. After PEG application, the
area was rinsed 5 to 6 times with calcium-containing lactated Ringer solution.
Functional Outcome Measures
Facial nerve axotomy was confirmed by observation of ipsilateral facial paralysis characterized by a loss of
eye blink reflex, complete loss of vibrissae movement, and abnormal posterior vibrissae orientation.
Animals in the 16- and 6-week studies were observed weekly to monitor recovery of eye blink reflex and
vibrissae movement. Eye blink reflex was tested by delivery of a brief direct stream of air to the eye using a
rubber bulb syringe. Recovery of eye blink reflex was defined by the ability to close the eyelid further than
halfway owing to voluntary muscular contraction. To monitor recovery of vibrissae movement, animals’
heads were stabilized using a rodent restraint cone (AIMS Inc) with the end cut, allowing the head to
emerge and the animal to whisk freely. Recovery of vibrissae movement was defined by the ability of
vibrissae to move in synchrony during consecutive whisks.
Branch Labeling
Buccal branch labeling was performed on the 14 animals in the 16-week study. A 1-cm incision was made 5
mm dorsal to the maxilla to expose the buccal branch. Once exposed, the buccal branch was transected, and
the proximal end was bathed in 2 μL of 4% fluorogold (Fluorochrome, LLC). Immediately after fluorogold
application, a small piece of absorbable gelatin (Gelfoam; Pfizer) was applied to the proximal end of the
nerve to sequester fluorogold to the area.
Buccal and mandibular branch labeling was performed on the 10 animals in the 6-week study. Fluorogold
labeling was performed as described above. To expose the mandibular branch, a 1-cm anterior-auricular
incision was made in the rostral-caudal direction. Once exposed, the mandibular branch was transected and
DiI crystals (Thermo Scientific) were applied to the proximal nerve end. A small piece of absorbable gelatin
was applied to the proximal end of the mandibular branch to keep the DiI in contact with the nerve.
Tissue Analysis
In all experiments, 1 week after branch labeling, animals were anesthetized using a mixture of ketamine
hydrochloride and xylazine hydrochloride and perfused with phosphate-buffered saline solution followed by
4% paraformaldehyde. The brain and brainstem were removed, postfixed in 4% paraformaldehyde
overnight, and transferred to a 30% sucrose solution until sectioned.
The pons from each animal was prepared for cryosectioning. Five slide sets were collected (Superfrost
slides; Thermo Scientific) with sections cut at 20 μm. One slide per set was Nissl stained to allow for
visualization of the entire FMN and prevent double counting. Tissue with only buccal branch labeling (16-
and 1-week studies) was stained with cresyl violet, and tissue with buccal and mandibular branch labeling
(6-week study) was stained with fluorescent Nissl (NeuroTrace, ThermoFisher Scientific). Fluorescent Nissl
staining was used owing to cresyl violet stain ablation of DiI tracing. A map of the rat FMN was used to
assess myotopic organization (Figure 2A).  The middle 7 to 8 stained FMN sections were used for
quantification. Sections were quantified if all subnuclei were visible and the map fit without resizing. Image
processing and counting were performed blinded using photo editing software (Photoshop CS6; Adobe). In
the 16- and 6-week studies, total number of motoneurons, number of motoneurons with buccal branch
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projections, and number of motoneurons with misguided projections to the buccal branch were quantified.
In the 6-week study, the numbers of motoneurons with mandibular branch projections, motoneurons with
misguided projections to the mandibular branch, and double-labeled motoneurons were counted.
Bilateral orbicularis oculi tissue from animals in the 1-week study was collected to examine neuromuscular
junction innervation. Orbicularis oculi tissue was cryosectioned at 20 μm and collected on slides.
Immunocytochemistry was performed on sections from the injured and uninjured sides using primary
antibody (antineurofilament, 1:200 dilution; Aves Laboratories) overnight at 4°C, followed by a 1-hour
incubation with a donkey antichicken secondary antibody (Alexa Fluor 488, 1:200 dilution; Jackson
ImmunoResearch) and a conjugated α-bungarotoxin primary antibody (Alex-555, 1:800 dilution; Molecular
Probes). All imaging was performed on an inverted fluorescent microscope (Bx50; Olympus).
Data Analysis
One-way analysis of variance using the Tukey post hoc test was performed on measures with 3 groups.
Unpaired t tests were performed on measures of double-labeled motor neurons and behavior data.
Results
Functional Outcomes
Among the 40 male rats, ipsilateral facial paralysis consisting of a loss of eye blink reflex and complete loss
of vibrissae movement was seen in all animals immediately after FNA. Passive eyelid movement due to
retraction of the eye was observed (owing to orbicularis oculi contraction) but distinguished from active
eyelid closure by video analysis. After reaching recovery, eye blink reflex on the injured side was slower
and often resulted in incomplete eyelid opening after blinking compared with the uninjured side. Visible
vibrissae movement typically began 2 to 3 weeks after injury and repair and consisted of independent
uncoordinated vibrissae osculation. After reaching recovery, whisking function remained slow and consisted
of smaller whisking amplitudes compared with the uninjured side.
In our 16-week study, the addition of PEG to neurorrhaphy resulted in a mean (SEM) time to eye blink
recovery of 3.57 (0.88) weeks (95% CI, −2.8 to 1.9 weeks; P = .70), which provided no benefit beyond
neurorrhaphy alone (mean [SEM] time to recovery, 4.00 [0.72] weeks; 95% CI −3.6 to 2.4; P = .69). Mean
(SEM) time to recovery of whisking function in the PEG group was 5.00 (0.82) weeks, compared with 5.57
(1.20) weeks in the neurorrhaphy-alone group. In the 6-week study, not all animals reached recovery by the
end of the study; thus, the mean number of weeks for recovery was not calculated. Of interest, the
percentage of rats reaching recovery for eye blink reflex (2 of 5 [40%] vs 1 of 5 [20%]) and whisking (4 of 5
[80%] vs 3 of 5 [60%]) by week 6 favored the suture-only group (Table).
Motoneuron Survival and Amount of Axonal Regrowth
Motoneuron survival after peripheral nerve injury in Wistar rats is high, with most studies showing 75% or
greater survival.  Motoneuron survival of 90% was seen in the 16-week (mean, 132.1 motoneurons
per tissue section; 95% CI, −21.0 to 8.4; P = .13) and 6-week (mean, 131.1 motoneurons per tissue section;
95% CI, −11.0 to 10.0; P = .06) studies, indicating that PEG had no added benefits or adverse effects on
motoneuron survival (Figure 3A and B).
To examine regrowth, the number of motoneurons routing projections to the buccal branch was quantified in
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the 16-week study by counting the number of fluorogold-labeled motoneurons (Figure 3C). Although not
significant, a decrease in the number of fluorogold-labeled motoneurons was seen in the PEG-treated
animals (mean, 132.1 motoneurons per tissue section; 95% CI, −8.3 to 26.0; P = .29). Based on this decrease
and plateaued functional outcomes 5 weeks after repair, our 6-week study examined axonal regrowth in the
buccal and mandibular branches. Six weeks after repair, no significant differences were seen between
groups (mean, 36.7 motoneurons per tissue section; 95% CI, −12 to 10; P = .48). Both surgical groups
showed a decreasing number of motoneurons with buccal branch projections compared with uninjured
controls, whereas the number of motoneurons with mandibular branch projections were unaltered (mean,
25.2 motoneurons per section; 95% CI, −14.0 to 15.0; P = .99) (Figure 3D and E).
Specificity of Regrowth
After injury, the myotopic organization of the FMN is disrupted.  Disruption results from regenerating
axons being misguided to incorrect targets. This miswiring contributes to a loss of coordinated muscle
recruitment and facial synkinesis.  In uninjured animals, motoneurons from the lateral, dorsal, and
intermediate subnuclei projected to the buccal and mandibular branches (Figure 2B and D). After repair,
motoneurons in the ventromedial and medial subnuclei also projected to the buccal and mandibular
branches, contributing to disrupted myotopic organization (Figure 2C and E).
The 16- and 6-week studies showed a significant increase in the number of motoneurons with misguided
projections to the buccal branch. The addition of PEG showed no benefit over suturing alone at 16 weeks
(mean, 15.3% motoneurons with misguided projections; 95% CI, −7.2% to 11.0%; P = .84) and 6 weeks
(mean, 17.3% motoneurons with misguided projections; 95% CI, −5.5% to 6.5%; P = .97) (Figure 4A and
B). Similarly, in the 6-week study, we found a significant increase in the number of motoneurons with
misguided projections to the mandibular branch in both surgical groups (mean, 8.5% motoneurons with
misguided projections; 95% CI, −21.5% to −3.2%; P = .01). The addition of PEG showed no benefit beyond
suturing alone (mean, 12.1% motoneurons with misguided projections; 95% CI, −8.2% to 9.2%; P = .98) (
Figure 4C).
In the rat facial motor system, it is well established that motoneurons guide their axonal projections to only
1 branch of the facial nerve.  We found double-labeled motoneurons, indicating motoneurons guiding
outgrowths to multiple facial nerve branches (Figure 2F). These aberrant branching motoneurons are
another contributor to facial synkinesis. No significant difference in aberrant branching was seen between
surgical groups (mean, 2.53 motoneurons with projections to the buccal and mandibular branches; 95% CI,
−3.54 to 2.06; P = .53) (Figure 4D).
Wallerian Degeneration
One of the first changes seen in the wallerian degeneration of motor axons after peripheral nerve injury is
denervation of the neuromuscular junction 12 to 20 hours after injury.  Neuromuscular junction
reinnervation begins 3 weeks after injury, with numerous neuromuscular junctions being reinnervated by 4
weeks, but this time is highly dependent on the distance of regrowth required.  To assess the association
of PEG with wallerian degeneration at the level of the neuromuscular junction, innervation of orbicularis
oculi tissue was evaluated from the injured and uninjured side of each animal in the 1-week study. We
found fully innervated neuromuscular junctions on the uninjured side of all animals but were unable to find
any innervated neuromuscular junctions on the injured side of animals in either surgical group from the 1-
week study (eFigure 1 in the Supplement).
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Discussion
Numerous studies have shown the efficacy of PEG in the treatment of spinal nerve and cord injury, but to
our knowledge, use of PEG has not been evaluated in the repair of cranial nerve injuries.  Based on the
ability of PEG to improve functional and anatomical outcomes after other nervous system injuries, we
hypothesized that PEG would improve recovery from facial nerve injury. However, the addition of PEG
provided no additional benefit beyond suturing alone.
This series of studies began with the 16-week study showing no acceleration of functional recovery when
PEG was added to neurorrhaphy. These functional outcome data in conjunction with the anatomical data
from the 16-week study provided the basis for the 6-week study. Of interest, in the 6-week study, both
functional outcome measures were impaired by the addition of PEG, resulting in fewer animals reaching
recovery by week 6.
Facial synkinesis is a result of various factors after repair, including the amount of axonal regrowth,
specificity of regrowth, and aberrant branching.  Mattsson et al  evaluated the amount of regrowth through
neuronal labeling via intramuscular injection and, 6 weeks after neurorrhaphy, they found that the number
of labeled facial motoneurons began to increase beyond uninjured levels and gradually increased until week
16. To assess the amount of regrowth in specific branches, branch labeling was used at 16 and 6 weeks after
repair. Although not significant, the number of motoneurons projecting to the buccal branch decreased in
both surgical groups 6 weeks after repair. In the 16-week study, this decrease reached control levels in the
suture-only group but not in the PEG-treated group. This trend coincides with unpublished data from our
laboratory (C.L.W., K.J.J., and B.L.B.; completed September 2017) that demonstrated a decrease in the
number of motoneurons with buccal branch projections at 16 postoperative weeks when PEG was combined
with systemic testosterone administration, which has been shown to accelerate axon regrowth.  In the
mandibular branch, the number of labeled motoneurons was similar to uninjured levels in both surgical
groups by week 6. These results suggest that PEG limits the amount of long-term regrowth in some facial
nerve branches. This limitation results from fewer axonal outgrowths being recruited to a branch or fewer
outgrowths being maintained over time. The number of outgrowths is heavily affected by the amount of
trophic influence to which the nerve branch is subjected.  With the mandibular branch of the rat projecting
to the whisker pad, upper lip, and lower lip, it may have greater trophic influence on outgrowths, resulting in
the recruitment and/or maintenance of a greater number of outgrowths compared with branches such as the
buccal, which projects to only 1 area.
Specificity of regrowth was evaluated 16 and 6 weeks after repair by assessing myotopic organization of the
FMN and aberrantly branching motoneurons. In both surgical groups at both points, a significant disruption
in the myotopic organization of the FMN occurred. In addition, similar numbers of aberrantly branching
motoneurons were found in both surgical groups, denoting motoneurons routing outgrowths to the buccal
and mandibular branches. These outcomes indicate that PEG offers no benefit in relation to specificity of
regrowth after injury.
Previous studies have found that PEG helps to retard wallerian degeneration after injury.  The first
anatomical sign of wallerian degeneration by motoneurons is neuromuscular junction denervation; therefore,
we evaluated the neuromuscular junction for signs of wallerian degeneration in our 1-week study.  We
found no evidence of innervated neuromuscular junctions on the injured side of either group, but fully
innervated neuromuscular junctions were found on the uninjured side of all animals. Although PEG may
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alter degeneration of axons near the injury site, we found no evidence of PEG leading to full retardation of
wallerian degeneration based on our assessment of neuromuscular junction innervation. However, this
finding does not exclude the possibility of wallerian degeneration near the repair site. It is plausible that
enough wallerian degeneration occurs in the nerve to reduce target musculature innervation, because the
present study did not assess the extent of axonal regrowth distal to the injury site. Based on the present
study, it is therefore difficult to determine whether PEG fusion and thus reduction in distal wallerian
degeneration occur in our facial nerve injury model compared with what is described in sciatic nerve repair.
Limitations
Functional and anatomical outcomes of the present study demonstrate that PEG provides no benefit beyond
neurorrhaphy alone in the surgical repair of facial nerve injury, but many questions remain unanswered.
Although PEG fusion may limit the number of outgrowths, polyinnervation of the facial musculature may
contribute to impaired functional outcomes. Guntinas-Lichius et al  found polyneural innervation despite a
reduction in the number of outgrowths. In the present study, polyneural innervation was not evaluated and
may further elucidate the association of PEG with anatomical and functional outcomes. Also pertinent is the
potential for autonomic reinnervation of skeletal muscle, which not only has the potential to affect recovery
of whisking function, but may have implications in polyneural innervation seen when the number of
outgrowths after repair is decreased.  We did not histologically evaluate the suture site or distal nerve after
repair, and to our knowledge, no studies using PEG have done so. Thus, we cannot rule out the possibility
that the nonspecific fusing of the neuronal membranes via PEG may produce a physical barrier altering
regrowth. Future studies are needed to examine this possibility and further clarify the effect of PEG on
neuronal regeneration. Last, future studies should also evaluate regrowth in other branches of the facial
nerve. This evaluation will help to determine whether PEG affects regrowth in branches with various
distances to target innervation.
One limitation of the facial nerve injury model compared with a sciatic model is the size of the nerve. In the
sciatic nerve, PEG fusion is confirmed by compound action potential measurement. The rat facial nerve
model does not allow for compound action potential measurements owing to anatomical restrictions.
Conclusions
Polyethylene glycol fusion has shown efficacy in the surgical repair of spinal nerve injuries, but this finding
was not replicated in facial nerve injury repair. This discrepancy is likely a result of differences between
injury models. The sciatic nerve is a mixed sensory and motor nerve at the level of injury, and sciatic axons
have a greater distance to regenerate before reaching their targets. Based on the findings of the present
study, we do not recommend the use of PEG for the treatment of facial nerve injury because it provided no
benefit beyond suturing alone.
Notes
Supplement.
eFigure. Immunostained Orbuclaris Oculi Tissue Sections
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Figure 1.
Anatomy of the Rat Facial Nerve and Facial Nucleus
A, The main trunk of the facial nerve forms 5 main branches after exiting the stylomastoid foramen (adapted from Hohman
et al,  JAMA Facial Plast Surg. 2014;16(1):20-24. doi:10.1001/jamafacial.2013.1431). B, Nissl-stained pontine section
shows the rat facial motor nucleus outlined bilaterally. Scale bar = 1000 μm.
Figure 2.
Organization of the Facial Motor Nucleus
A, Nissl-stained rat facial motor nucleus is subdivided into the following 5 main subnuclear groups: lateral (L), dorsal (D),
intermediate (I), ventromedial (VM), and medial (M). B, Overlay of motoneurons projecting to the buccal branch (red) in
an uninjured animal. C, Buccal branch projecting motoneurons (red) from an injured animal; yellow arrows indicate
motoneurons with misguided projections. D, Overlay of motoneurons projecting to the mandibular branch (blue) in an
uninjured animal. E, Mandibular branch projecting motoneurons (blue) from an injured animal; yellow arrows indicate
motoneurons with misguided projections. F, Overlay of motoneurons projecting to the buccal (red) and mandibular (blue)
branches; yellow arrows indicate motoneurons projecting to both branches. Scale bar = 200 μm.
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Table.
Recovery of Function in the 6-Week Study
Function Postoperative Time, wk No. (%) Animals Recovering
1 2 3 4 5 6
Eye blink recovery
Suture (n = 5) 0 0 0 1 0 1 2 (40)
Suture plus PEG (n = 5) 0 0 0 1 0 0 1 (20)
Whisking recovery
Suture (n = 5) 0 0 0 0 2 2 4 (80)
Suture plus PEG (n = 5) 0 0 0 0 1 2 3 (60)
Abbreviation: PEG, polyethylene glycol.
Figure 3.
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Motoneuron Survival and Amount of Regrowth
Blue lines indicate mean values; error bars, 95% CIs. PEG indicates polyethylene glycol.
Figure 4.
Functional and Anatomical Outcomes of Facial Nerve Injury With Application of Polyethylene Glycol in a Rat Model
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439742/?report=printable[8/9/2019 12:11:41 PM]
Misguided Regrowth and Aberrant Branching
Blue lines indicate mean values; error bars, 95% CIs. PEG indicates polyethylene glycol.
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